J Alzheimers Dis

• 

  Publication Venue For

  • Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction. 2021
  • APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid..  79:511-530. 2021
  • Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort..  79:1203-1211. 2021
  • A Prospective Longitudinal Study of Caregivers of Community Dwelling Persons with Severe Dementia (PISCES): Study Protocol..  75:403-416. 2020
  • Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis..  76:207-215. 2020
  • Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease..  74:563-578. 2020
  • How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?.  74:625-636. 2020
  • Late-Life Cognitive Trajectories and their Associated Lifestyle Factors..  73:1555-1563. 2020
  • Metabolic and Neurocognitive Changes Following Lifestyle Modification: Examination of Biomarkers from the ENLIGHTEN Randomized Clinical Trial..  77:1793-1803. 2020
  • The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction..  75:1319-1328. 2020
  • A δ Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative..  67:67-79. 2019
  • Association Between Insulin Resistance, Plasma Leptin, and Neurocognition in Vascular Cognitive Impairment..  71:921-929. 2019
  • Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers..  67:911-921. 2019
  • Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology..  72:35-43. 2019
  • Accuracy of Inferred APOE Genotypes for a Range of Genotyping Arrays and Imputation Reference Panels..  64:49-54. 2018
  • Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension..  66:1095-1104. 2018
  • Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study..  64:1137-1148. 2018
  • Effectiveness of a Personalized Brain-Computer Interface System for Cognitive Training in Healthy Elderly: A Randomized Controlled Trial..  66:127-138. 2018
  • Homocysteine and Cerebral Atrophy: The Epidemiology of Dementia in Singapore Study..  62:877-885. 2018
  • Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery-20181..  66:1-10. 2018
  • Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment..  64:137-148. 2018
  • Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment..  55:1123-1130. 2017
  • The Association Between Retinal Neuronal Layer and Brain Structure is Disrupted in Patients with Cognitive Impairment and Alzheimer's Disease..  54:585-595. 2016
  • The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial..  52:1299-1310. 2016
  • Validation of the Total Cerebrovascular Disease Burden Scale in a Community Sample..  52:1021-1028. 2016
  • Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians..  49:991-1003. 2016
  • Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment..  49:1191. 2016
  • Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data..  46:695-702. 2015
  • Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease..  45:45-56. 2015
  • Specialized Pro-Resolving Mediators from Omega-3 Fatty Acids Improve Amyloid-β Phagocytosis and Regulate Inflammation in Patients with Minor Cognitive Impairment..  48:293-301. 2015
  • Subcortical Atrophy in Cognitive Impairment and Dementia..  48:813-823. 2015
  • Retinal microvasculature in Alzheimer's disease..  42 Suppl 4:S339-S352. 2014
  • Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice..  31:359-369. 2012
  • Mitochondrial DNA sequence variation associated with dementia and cognitive function in the elderly..  32:357-372. 2012
  • The importance of being connected..  24:247-251. 2011
  • Genome-wide scan of copy number variation in late-onset Alzheimer's disease..  19:69-77. 2010
  • Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA)..  18:665-675. 2009
  • The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited..  17:807-815. 2009